Plant-Based Biologics Is Fastest Growing Segment Fueling The Growth Of Plant-Based Biologics Market

Pooja Khodke

Plant-Based Biologics Is Fastest Growing Segment Fueling The Growth Of Plant-Based Biologics Market

The global Plant-Based Biologics Market is estimated to be valued at Us$ 21.45 Million in 2023 and is expected to exhibit a CAGR Of 3.4% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.

Plant-based biologics are proteins expressed in plant such as tobacco, alfalfa, corn and others. These biologics have advantages over traditional therapeutics in terms of better efficacy, safety and high yields. With increasing prevalence of chronic diseases, the need for cost-effective and scalable production of biologics has been growing significantly.

Market Overview:

Plant-based biologics are proteins expressed and grown in genetically engineered plants to yield functional therapeutic drugs. They have applications in conditions such as cancers, diabetes, cardiovascular diseases among others. Plant-based biologics offer rapid production scale-up and purification at low-cost making them viable alternative to microbial and animal cell culture systems.

Market key trends:

One of the key trends in the plant-based biologics market is the shift from first generation transgenic plant platforms to newer transient and suspension cell platforms. Transient platforms enable rapid production in non-transgenic plants by avoiding stable transformation and related regulatory barriers. Companies are also focusing on proprietary suspension cell platforms that can produce biologics devoid of plant-specific glycan residues, thereby enhancing safety and efficacy. Another major trend is the numerous preclinical and clinical stage pipeline candidates for diseases with high unmet need such as hepatitis C, hemophilia and cancer. This is expected to translate into new product approvals and commercialization in the coming years.

Segment Analysis

The global plant-based biologics market is segmented on the basis of product, application, source, and end user. The product segment is further divided into monoclonal antibodies, vaccines, insulin, glucagon-like peptide-1, erythropoietin and other recombinant non-glycosylated proteins. Among these, the monoclonal antibodies segment dominates the market owing to rising demand for plant-made monoclonal antibodies to treat various chronic and infectious diseases.

Key Takeaways

The Global Plant-Based Biologics Market Demand is expected to witness high growth, exhibiting CAGR of 3.4% over the forecast period, due to increasing demand for sustainable and affordable biologics.

Market size:

The global plant-based biologics market is expected to witness high growth, exhibiting CAGR of 3.4% over the forecast period, due to increasing demand for low-cost and sustainable alternatives to conventional biologics.

Regional analysis:

Regionally, North America holds the major share of the global plant-based biologics market and is expected to remain dominant over the forecast period. This is attributed to strong government funding, established biologics industry and growing focus on the development of next-generation biologics in the region.

Key players:

Key players operating in the plant-based biologics market are Leaf Expression Systems, Zea Biosciences, Planet Biotechnology Inc., InVitria, PlantForm Corporation, IBIO, Inc., Mapp Biopharmaceutical, Inc., Pfizer Inc., Ventria Bioscience Inc., Medicago Inc., Eleva GmbH, Kentucky Bioprocessing, LLC, Solarvest Bioenergy Inc., and Byondis B.V.

Pooja Khodke

Plant-Based Biologics Market Estimated to Witness High Growth Owing to Increasing Consumer Preference for Natural Alternatives

Omkar Patel 2023-12-26

These platform-based cost advantages will continue to drive the adoption of plant-based biologics over the forecast period. This is enabling greater acceptance and commercialization of therapeutic proteins produced from plant systems. Complex recombinant protein drugs produced in microbial or animal cells typically entail high development and production costs. Induction of plant-based synthetic biology and advanced manufacturing holds promise to augment protein yields and drive down production costs. As these innovative trends mature, they will strengthen the competitiveness of plant-based biologics to increasingly replace traditional therapeutics.

Global Plant-based Biologics Market Is Estimated To Witness High Growth Owing To Increasing Demand for Sustainable and Eco-Friendly Products

Pooja salve 2023-08-31

The global Plant-based Biologics market is estimated to be valued at US$ 19. Key Takeaways: - The Global Plant-based Biologics Market Demand is expected to witness high growth, exhibiting a CAGR of 3. These companies are investing in research and development activities to enhance their plant-based expression systems and expand their product portfolios. In conclusion, the global plant-based biologics market is poised for significant growth as the demand for sustainable and eco-friendly products continues to rise. With their numerous advantages and increasing adoption, plant-based biologics offer a viable alternative to traditional biologics and have the potential to revolutionize the pharmaceutical industry.

Plant-based Biologics Market Update: Fast Change Strategies for 2021-2025

neetisoni 2021-06-16

Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/reports/142163-global-plant-based-biologics-market Latest released the research study on Global Plant-based Biologics Market, offers a detailed overview of the factors influencing the global business scope.

Plant-based Biologics Market Market Data Breakdown and Market Segmentation: What's Trending in Market:Strict Government RegulationChallenges:High Cost for R& DRestraints:Increase in the Number of Chronic Diseases and Consequent Demand for BiologicsAdvancements in Plant Biotechnology AreaMarket Growth Drivers:Fraunhofer IME (Germany)PlantForm (Canada)Mapp Biopharmaceautical (United States)Kentucky BioProcessing, Inc. (United States)Icon Genetics GmbH (Germany)Medicago, Inc. (Canada)iBio Inc. (United States)Greenovation Biotech GmbH (Germany)Ventria Bioscience Inc. (United States) Enquire for customization in Report @: https://www.advancemarketanalytics.com/reports/142163-global-plant-based-biologics-market Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & AfricaCountry Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.

– Latest industry influencing trends and development scenario – Open up New Markets – To Seize powerful market opportunities – Key decision in planning and to further expand market share – Identify Key Business Segments, Market proposition & Gap Analysis – Assisting in allocating marketing investments Strategic Points Covered in Table of Content of Global Plant-based Biologics Market Market:Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Market Keyword without Region marketChapter 2: Exclusive Summary – the basic information of the Plant-based Biologics Market Market.Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Plant-based Biologics MarketChapter 4: Presenting the Plant-based Biologics Market Factor Analysis, Post COVID Impact Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.Chapter 5: Displaying the by Type, End User and Region/Country 2015-2020Chapter 6: Evaluating the leading manufacturers of the Plant-based Biologics Market market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company ProfileChapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2021-2026)Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source Finally, Plant-based Biologics Market Market is a valuable source of guidance for individuals and companies in their decision framework.

When it comes to secondary sources Company's Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were given primary weight-age.

Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source.

Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market.

Plant-Based Meat Market is Anticipated to Reach US$13 Bn by 2026

Fairfield Market Research 2022-12-21

9% between 2021 and 2026, worldwide demand for plant-based meat products is likely to account for the revenue of over US$13 Mn. A new Fairfield Market Research study indicates that the growth of plant-based meat market will remain influenced by the exploding popularity of vegan, plant-based, gluten-free, and cruelty-from trends among consumers worldwide. , pea protein will continue to be the most sought-after segment in plant-based meat market, projects the report. The foodservice industry is also showcasing growing interest around plant-based meat products. com/report/plant-based-meat-market/request-sample About UsFairfield Market Research is a UK-based market research provider.

The Plant Based Milk Market To Put Up With The Digital Wave

sheetal singh 2022-04-18

com/samples/31413Consumption of plant-based milk is witnessing high growth as consumers are shifting toward healthy and adulterated-free beverage items. Key Takeaways from Market StudyThe market for plant-based milk is expected to expand at CAGRs of 9. The European plant-based milk market is currently pegged at 2,148,385. To connect with our sales representative@ sales@persistencemarketresearch. com/checkout/31413About us: Persistence Market ResearchContact us:Persistence Market Research Address – 305 Broadway, 7th Floor, New York City,NY 10007 United StatesU.

Plant-based Vaccines Market is Estimated to Witness High Growth Owing to the Increasing Demand for Sustainable and Safe Vaccines

Pooja Khodke 2023-10-16

The global Plant-based Vaccines Market is estimated to be valued at US$ 43. The need for sustainable and safe vaccines is driving the growth of the plant-based vaccines market as they eliminate the risk of contamination associated with traditional vaccines. In conclusion, the plant-based vaccines market is witnessing high growth due to the increasing demand for sustainable and safe vaccines. Key TakeawaysThe global Plant-Based Vaccines Market is expected to witness high growth, exhibiting a CAGR of 49. In terms of regional analysis, North America is anticipated to be the fastest-growing and dominating region in the plant-based vaccines market.

WHO TO FOLLOW